Lambros Tselikas

5.7k citations
116 papers · 2.6k indexed · h-index 24

Lambros Tselikas

107 papers receiving 2.5k citations

Peers

Lambros Tselikas
Comparison fields: 5 of 103
  • Hepatology 506
  • Oncology 1.0k
  • Geriatrics and Gerontology 125
  • Pulmonary and Respiratory Medicine 705
  • Surgery 818
Replace Naoto Gotohda with:
Naoto Gotohda Japan
Po‐Chin Liang Taiwan
Terumitsu Sawai Japan
Masaru Konishi Japan
Xin‐Zu Chen China
Francesca Ratti Italy
Konstantinos I. Votanopoulos United States
Tomohiro Iguchi Japan
Chao‐Hui Zheng China
Su‐Jin Shin South Korea
Lambros Tselikas relative to Naoto Gotohda Japan Naoto Gotohda's profile →
Citations per field
00.5×
Naoto Gotohda · 1×
Citations per year

Countries citing papers authored by Lambros Tselikas

Since Specialization
Citations

This map shows the geographic impact of Lambros Tselikas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lambros Tselikas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lambros Tselikas more than expected).

Fields of papers citing papers by Lambros Tselikas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lambros Tselikas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lambros Tselikas. The network helps show where Lambros Tselikas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lambros Tselikas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lambros Tselikas Line = papers co-authored together Lambros Tselikas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202417
3 20240
4 202411
5 202410
6 20242
7 202310
8 20231
9 20230
10 20231
11 20237
12 20232
13 202126
14 202022
15 202013
16 202023
17 20202
18 201821
19 201713
20 201664

About Lambros Tselikas

Lambros Tselikas is a scholar working on Hepatology, Oncology and Health Informatics, having authored 116 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (35 papers), Management of metastatic bone disease (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Cancer Immunotherapy and Biomarkers (15 papers), Medical Imaging and Pathology Studies (10 papers), Neuroblastoma Research and Treatments (10 papers), Lung Cancer Research Studies (10 papers) and Renal cell carcinoma treatment (9 papers). The work is most often cited by research in Hepatology (506 citations), Oncology (1.0k citations) and Geriatrics and Gerontology (125 citations). Lambros Tselikas has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Thierry de Baère, Frédèric Deschamps, Aurélien Marabelle, Roch Houot, Alexis Laurent, Alain Luciani, F. Pigneur, Antoine Hakimé, Daniel Azoulay and Michel Ducreux. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026